Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Uro Gen Pharma Ltd. Transaction History

Yahav Achim Ve Achayot Provident Funds Management CO Ltd.

$28.3 Million
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 17, 2021	BUY	$14.31 - $18.39 $362,472 - $465,818	25,330 New	25,330 $426,000

Others Institutions Holding URGN

# of Institutions

136

Shares Held

36.2M

Call Options Held

57.7K

Put Options Held

9.8K

Rtw Investments, LP New York, NY

3.83M
Shares

$39.8 Million
0.67% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

2.93M
Shares

$30.4 Million
0.06% of portfolio
Menora Mivtachim Holdings Ltd.

2.3M
Shares

$23.9 Million
0.15% of portfolio
Black Rock Inc. New York, NY

2.19M
Shares

$22.8 Million
0.0% of portfolio
Toronto Dominion Bank Toronto, Ontario, A6

1.75M
Shares

$18.1 Million
0.03% of portfolio

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $236M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yahav Achim Ve Achayot Provident Funds Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yahav Achim Ve Achayot Provident Funds Management CO Ltd. with notifications on news.

Account